HTL Biotechnology video - Beyond, Together.
Feel the difference with HTL inside !
HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.
Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.
At HTL Biotechnology, our mission is to unleash the potential of Hyaluronic Acid and biopolymers.
For over 30 years, our teams have been developing and perfecting a pharmaceutical-grade biopolymer platform that provides customized solutions to pharmaceutical laboratories and medical device manufacturers worldwide in therapeutic areas such as Ophthalmology, Rheumatology, Dermatology and Medical Aesthetics.
HTL BIOTECHNOLOGY
-
FR
-
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Other Content from HTL BIOTECHNOLOGY (1)
-
News HTL Biotechnology at IMCAS World congress Paris 2024
IMCAS, the world’s leading congress dedicated to dermatology, plastic surgery, and aesthetics.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance